Brasília – The National Cancer Institute (Inca) releases new data estimating 73,610 new breast cancer cases in Brazil this year, as part of the October Pink awareness campaign. The findings are presented in the publication Control of Breast Cancer in Brazil: Data and Numbers 2025, which compiles statistics on incidence, mortality, risk factors, prevention, access to exams, and treatment to support health professionals and policymakers.

According to Inca, breast cancer remains the leading cause of cancer deaths among women in Brazil, with over 20,000 deaths recorded in 2023. Between 2020 and 2023, mortality decreased among women aged 40 to 49. The Southeast region shows the highest incidence, while Santa Catarina leads among individual states. In mortality rates, the South, Southeast, and Northeast regions rank highest, with Roraima, Rio de Janeiro, and Rio Grande do Sul showing the greatest figures.

Renata Maciel, head of Inca’s Division for Early Detection and Network Organization, noted an improvement in the time between diagnosis and first treatment, particularly in the South, where most cases begin treatment within 60 days. However, she emphasized that screening coverage remains low, with rates varying from 5.3% in parts of the North to 33% in Espírito Santo, far below the 70% target.

José Barreto, director of the Cancer Care Department at the Ministry of Health, highlighted that early diagnosis and screening are part of the federal program Agora Tem Especialista (“Now There’s a Specialist”), which aims to reduce waiting times and improve treatment access.

Source: Agência Brasil

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com